Treatment of reactive perforating collagenosis with two forms of phosphodiesterase 4 inhibition

Documenti analoghi

• Behandlung der reaktiven perforierenden Kollagenose mit zwei Phosphodiesterase‐4‐Hemmern
  di: Sabrina Schundler, et al.
  Pubblicazione: (2025)
• Tofacitinib treatment for acquired reactive perforating collagenosis
  di: Xingyu Jiang, et al.
  Pubblicazione: (2025)
• Acquired reactive perforating collagenosis in systemic lupus erythematosus successfully treated with belimumab
  di: Shin Iinuma, et al.
  Pubblicazione: (2025)
• Acquired perforating dermatoses and cabozantinib: A novel cutaneous toxicity
  di: Diego Soto‐García, et al.
  Pubblicazione: (2024)
• Extensive confluent and reticulated papillomatosis arising following initiation of paclitaxel and carboplatin
  di: Olivia R. Negris, et al.
  Pubblicazione: (2024)